CRIS Current Research Information System

BOLONDI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.623
EU - Europa 10.961
AS - Asia 5.700
AF - Africa 731
SA - Sud America 45
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 13
Totale 33.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.584
GB - Regno Unito 3.337
CN - Cina 1.905
VN - Vietnam 1.847
IT - Italia 1.515
SE - Svezia 1.483
DE - Germania 1.395
SG - Singapore 1.057
UA - Ucraina 785
IN - India 619
IE - Irlanda 512
FR - Francia 472
RU - Federazione Russa 461
ZA - Sudafrica 266
EE - Estonia 258
TG - Togo 256
CH - Svizzera 241
BG - Bulgaria 136
JO - Giordania 126
FI - Finlandia 87
CI - Costa d'Avorio 83
BE - Belgio 68
NG - Nigeria 66
SC - Seychelles 54
IR - Iran 39
GR - Grecia 37
CA - Canada 36
JP - Giappone 32
HR - Croazia 30
NL - Olanda 26
RO - Romania 23
EU - Europa 21
AT - Austria 18
ES - Italia 16
BR - Brasile 15
LB - Libano 14
PL - Polonia 13
CL - Cile 11
EC - Ecuador 9
MK - Macedonia 9
AU - Australia 8
KR - Corea 7
TR - Turchia 7
HK - Hong Kong 6
MY - Malesia 6
UZ - Uzbekistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CZ - Repubblica Ceca 5
LT - Lituania 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PE - Perù 5
AM - Armenia 4
BD - Bangladesh 4
DK - Danimarca 4
HU - Ungheria 4
IL - Israele 4
MU - Mauritius 3
PT - Portogallo 3
SI - Slovenia 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
ID - Indonesia 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
PH - Filippine 2
PK - Pakistan 2
RS - Serbia 2
AL - Albania 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
SA - Arabia Saudita 1
SM - San Marino 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 33.099
Salva come PNG Salva come JPEG
Città #
Southend 3.061
Fairfield 2.110
Chandler 1.501
Ashburn 1.279
Dong Ket 1.265
Houston 1.005
Wilmington 989
Woodbridge 982
Singapore 904
Seattle 880
Ann Arbor 731
Cambridge 684
Princeton 676
Jacksonville 521
Dublin 511
Westminster 312
Nanjing 305
Padova 274
Bologna 260
Lomé 256
Berlin 216
Bern 213
Santa Clara 172
Saint Petersburg 159
Jinan 154
Sofia 136
Shenyang 135
Amman 126
Beijing 124
Nanchang 113
San Diego 108
Turin 100
Medford 99
Hebei 94
New York 93
Changsha 88
Mülheim 85
Abidjan 83
Helsinki 83
Boardman 81
Milan 81
Dearborn 75
Brussels 67
Abeokuta 66
Florence 66
Tianjin 61
Jiaxing 57
Zhengzhou 53
Guangzhou 52
Bremen 50
Falls Church 50
Mahé 50
Ningbo 46
Redmond 46
Norwalk 45
Los Angeles 44
Olalla 44
Des Moines 43
Redwood City 43
Shanghai 42
Haikou 34
Verona 33
Bühl 32
Rome 32
Mountain View 31
Hangzhou 30
Taiyuan 27
Tokyo 27
Kunming 25
Lanzhou 24
Toronto 24
Taizhou 22
Hyderabad 21
Paris 21
Pune 21
Washington 21
London 20
Kuban 18
Frankfurt am Main 16
Fuzhou 16
Wuhan 15
Ardabil 14
Chicago 14
Phoenix 14
Shijiazhuang 14
Frankfurt Am Main 13
San Venanzo 13
Hefei 12
Vienna 12
Costa Mesa 11
Lausanne 10
Leawood 10
Shenzhen 10
São Paulo 10
Amsterdam 9
Chengdu 9
Foshan 9
Harbin 9
Quito 9
Wuxi 9
Totale 22.770
Salva come PNG Salva come JPEG
Nome #
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 320
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 300
A modeling study of bilirubin kinetics during Molecular Adsorbent Recirculating System sessions. 224
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 223
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 208
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 207
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 199
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 199
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 189
Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. 186
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 184
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 182
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 181
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 176
Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma 171
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 169
Ablazione percutanea ecoguidata mediante radiofrequenza di piccoli noduli di HCC: fattori correlati all'esito clinico e alla recidiva di malattia 166
null 164
A new mathematical model for bilirubin kinetics during MARS sessions 162
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 157
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 156
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 154
Nozioni di ecografia Doppler e color-Doppler 151
Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm. 149
Linee guida A.I.S.F. per l'ipertensione portale. 147
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 145
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 145
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 144
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 144
LncRNAs as novel players in hepatocellular carcinoma recurrence 143
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 142
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 142
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 141
Assessment of liver fibrosis in trnsplant recipients with recurrent HCV infection: Usefulness of transient elastography. 141
Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. 140
ASSOCIATIONS OF THE -174 G/C INTERLEUKIN-6 GENE PROMOTER POLYMORPHISM WITH SERUM INTERLEUKIN -6 AND MORTALITY IN THE ELDERLY 138
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 138
Characterization of focal liver lesions with contrast-enhanced ultrasound. 137
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? 137
A case of inflammatory ascites. 137
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 136
A case of intractable pruritus in Turner's syndrome successfully treated with molecular adsorbent recirculating system. 136
Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma 136
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 136
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 135
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 135
Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. 134
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis 134
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 133
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 133
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 133
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 133
Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. 133
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 132
Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. 131
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging 131
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 131
Clinical impact of ultrasound-related techniques on the diagnosis of focal liver lesions 131
Celiac disease diagnosed through screening programs in at-risk adults is not associated with worse adherence to the gluten-free diet and might protect from osteopenia/osteoporosis 131
Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis 130
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 129
Clinical and diagnostic aspects of gluten related disorders 129
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 129
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 128
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. 128
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 128
Extracorporeal Detoxification for Hepatic Failure Using Molecular Adsorbent Recirculating System: Depurative Efficiency and Clinical Results in a Long-Term Follow-Up 128
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 128
A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease 126
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 126
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 126
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 126
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 126
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 125
Oncogenic role of miR-483-3p at the IGF2/483 locus. 125
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. 125
Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer 124
Caution in the use of boldo in herbal laxatives: a case of hepatotoxicity. 122
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives 122
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 122
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 121
null 121
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 121
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 120
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 120
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study 119
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 119
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. 118
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 118
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 117
Pharmaceutical composition and pharmaceutical kit for the treatment oh hepatocellular carcinoma 117
Role of Real-Time Contrast-Enhanced Ultrasound in the Assessment of Metastatic Portal Vein Thrombosis. 117
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): A phase 3, randomised, double-blind, placebo-controlled trial 117
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 116
Characterization of Small Nodules (1-3 cm) in Cirrhosis. The role of Perfusional Angiosonography, Spiral Computed Tomography and Double Contrast Magnetic Resonance 116
L'albumina 60 anni dopo: evidenze e prospettive. Dalla fisiologia alla clinica. 115
Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma. 115
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. 115
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 114
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 114
Totale 14.374
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.007 0 0 0 483 828 903 1.071 1.168 1.149 587 332 486
2020/20215.062 961 306 150 191 83 276 124 250 394 282 220 1.825
2021/20226.466 775 251 385 523 573 373 153 376 206 370 1.505 976
2022/20236.532 742 918 314 838 411 483 175 314 1.176 170 535 456
2023/20241.653 139 292 111 167 145 366 87 85 72 94 52 43
2024/20252.175 266 1.124 564 221 0 0 0 0 0 0 0 0
Totale 33.866